Not checkedNot checked for notices yet.
Therapeutic implications of prion diseases
Cao Chen, Xiaoping Dong
Biosafety and Health · 2021
doi:10.1016/j.bsheal.2020.09.001 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Prions are unconventional infectious agents that cause lethal transmissible neurodegenerative diseases in human and animals. Prions can be distinguished from other known pathogens by their lack of nucleic acids. The most essential process for prion propagation is conversion from normal cellular prion protein on the cell membrane to insoluble, limited protease digestion-resistant, pathogenic scrapie prion protein. For dozens of years, many pharmacological tools and interventions targeting different stages of disease progression have been developed and evaluated, and a few have been entered clinical trials. However, no approved prophylactic or therapeutic drugs for prion diseases are available. In this review, we summarize the current concepts in prion research and discuss advances in the research and development of drugs for the prevention and treatment of prion disease.
Abstract licence: CC BY-NC-ND
References137
- 15.
39 more references, whose wording the paper’s licence keeps private.
All 137 referencesReads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.